Growth Factor Regulation of Cell Cycle Progression in Mammary Epithelial Cells

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of mammary gland biology and neoplasia

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1023/B:JOMG.0000023585.95430.f4PMID 15082915
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Crosstalk Between the Insulin-Like Growth Factors and Estrogens in Breast Cancer

  2004cited by this paper
• Estrogen and Progestin Regulation of Cell Cycle Progression

  2004cited by this paper
• IGF-I: An Essential Factor in Terminal End Bud Formation and Ductal Morphogenesis

  2004cited by this paper
• Mitogenic Properties of Insulin-Like Growth Factors I and II, Insulin-Like Growth Factor Binding Protein-3 and Epidermal Growth Factor on Human Breast Epithelial Cells in Primary Culture

  2004cited by this paper
• Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells.

  2003cited by this paper
• The Cyclin-dependent Kinase Inhibitor p21CIP/WAF Is a Positive Regulator of Insulin-like Growth Factor I-induced Cell Proliferation in MCF-7 Human Breast Cancer Cells*

  2003cited by this paper
• 17β-Estradiol responsiveness of MCF-7 laboratory strains is dependent on an autocrine signal activating the IGF type I receptor

  2003cited by this paper
• Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells.

  2003influential reference
• Biphasic role of TGF‐β1 in signal transduction and crosstalk

  2003cited by this paper
• Local insulin-like growth factor-II mediates prolactin-induced mammary gland development.

  2003cited by this paper
• Biphasic role of TGF-beta1 in signal transduction and crosstalk.

  2003cited by this paper
• Synergistic proliferative action of insulin-like growth factor I and 17 beta-estradiol in MCF-7S breast tumor cells.

  2002influential reference
• Effects of ErbB-2 overexpression on mitogenic signalling and cell cycle progression in human breast luminal epithelial cells

  2002influential reference
• Paradigms of Growth Control: Relation to Cdk Activation

  2002influential reference
• Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action.

  2002cited by this paper
• Inducible dimerization of FGFR1

  2002cited by this paper
• Mitogenic Properties of Insulin-Like Growth Factors I and II, Insulin-like Growth Factor Binding Protein-3 and Epidermal Growth Factor on Human Breast Stromal Cells in Primary Culture

  2002cited by this paper
• Insulin-like Growth Factor I Triggers Nuclear Accumulation of Cyclin D1 in MCF-7S Breast Cancer Cells*

  2002cited by this paper
• Requirement for IGF-I in epidermal growth factor-mediated cell cycle progression of mammary epithelial cells.

  2002cited by this paper
• Differential sensitivity of cancer cells to inhibitors of the epidermal growth factor receptor family

  2002cited by this paper
• Non-malignant and Tumor-derived Cells Differ in Their Requirement for p27Kip1 in Transforming Growth Factor-β-mediated G1 Arrest*

  2002cited by this paper
• Inducible expression of FGF-3 in mouse mammary gland

  2002cited by this paper
• Altered p27(Kip1) phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor beta-mediated G(1) arrest.

  2002cited by this paper
• ErbB-2-induced mammary tumor growth: the role of cyclin D1 and p27Kip1.

  2002cited by this paper
• IGF-2 is a mediator of prolactin-induced morphogenesis in the breast.

  2002cited by this paper
• Altered p27Kip1 Phosphorylation, Localization, and Function in Human Epithelial Cells Resistant to Transforming Growth Factor β-Mediated G1 Arrest

  2002cited by this paper
• TGF-β Flips the Myc Switch

  2001cited by this paper
• Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects

  2001cited by this paper
• Inaugural Article: Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program

  2001cited by this paper
• Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.

  2001cited by this paper
• Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.

  2001cited by this paper
• ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.

  2001cited by this paper
• Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks.

  2001cited by this paper
• Growth-factor-dependent mitogenesis requires two distinct phases of signalling

  2001cited by this paper
• Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.

  2001cited by this paper
• Insulin/Insulin-like Growth Factor-I and Estrogen Cooperate to Stimulate Cyclin E-Cdk2 Activation and Cell Cycle Progression in MCF-7 Breast Cancer Cells through Differential Regulation of Cyclin E and p21WAF1/Cip1 *

  2001influential reference
• Constitutive MEK/MAPK Activation Leads to p27Kip1Deregulation and Antiestrogen Resistance in Human Breast Cancer Cells*

  2001cited by this paper
• TGF-beta flips the Myc switch.

  2001cited by this paper
• Correlation of p27 protein expression with HER‐2/neu expression in breast cancer

  2001cited by this paper
• Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds.

  2001cited by this paper
• Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models

  2001cited by this paper
• The Pezcoller lecture: cancer cell cycles revisited.

  2000cited by this paper
• Transforming growth factor-β and breast cancer: Transforming growth factor-β/SMAD signaling defects and cancer

  2000cited by this paper
• Reversible G1 Arrest Induced by Inhibition of the Epidermal Growth Factor Receptor Tyrosine Kinase Requires Up-regulation of p27KIP1 Independent of MAPK Activity*

  2000influential reference
• Cell cycle basis for the onset and progression of c-Myc-induced, TGFα-enhanced mouse mammary gland carcinogenesis

  2000cited by this paper
• TGFbeta signaling in growth control, cancer, and heritable disorders.

  2000cited by this paper
• Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.

  2000influential reference
• The Potentiation of Estrogen on Insulin-like Growth Factor I Action in MCF-7 Human Breast Cancer Cells Includes Cell Cycle Components*

  2000influential reference
• Transforming growth factor-β and breast cancer: Cell cycle arrest by transforming growth factor-β and its disruption in cancer

  2000influential reference
• Molecular mechanisms underlying ErbB2/HER2 action in breast cancer

  2000cited by this paper
• CDK inhibitors: positive and negative regulators of G1-phase progression.

  1999cited by this paper
• Hypothesis: Progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals.

  1999cited by this paper
• Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development.

  1999cited by this paper
• Activation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesis.

  1998cited by this paper
• Transforming growth factor-beta in breast cancer: a working hypothesis.

  1997cited by this paper
• A Specific Role for Cyclin D1 in Mammary Gland Development

  1997cited by this paper
• Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells

  1997cited by this paper
• Transforming growth factor-β in breast cancer: A working hypothesis

  1997cited by this paper
• Reciprocal changes in p27(Kip1) and p21(Cip1) in growth inhibition mediated by blockade or overstimulation of epidermal growth factor receptors.

  1997cited by this paper
• Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15

  1997cited by this paper
• Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development.

  1997cited by this paper
• Differential Modulation of G Cyclins and the Cdk Inhibitor p27 by Platelet-derived Growth Factor and Plasma Factors in Density-arrested Fibroblasts (*)

  1996cited by this paper
• Principles of CDK regulation

  1995cited by this paper
• Inhibitors of mammalian G1 cyclin-dependent kinases.

  1995cited by this paper
• Cell cycle: Regulatory events in G1 → S transition of mammalian cells

  1994cited by this paper
• Control of mammary epithelial cell DNA synthesis by epidermal growth factor, cholera toxin, and IGF-1: specific inhibitory effect of prolactin on EGF-stimulated cell growth.

  1994cited by this paper
• The biology of erbB-2/neu/HER-2 and its role in cancer.

  1994cited by this paper
• The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase.

  1994cited by this paper
• Mammalian G1 cyclins.

  1993cited by this paper
• Acute effects of growth factors on T-47D breast cancer cell cycle progression.

  1993cited by this paper
• Regulation of breast cancer cell cycle progression by growth factors, steroids and steroid antagonists.

  1992cited by this paper
• Effects of estrogen, epidermal growth factor, and transforming growth factor-alpha on the growth of human breast epithelial cells in primary culture.

  1992cited by this paper
• G1 events and regulation of cell proliferation.

  1989cited by this paper
• Ductal morphogenesis in the mouse mammary gland: evidence supporting a role for epidermal growth factor.

  1988cited by this paper
• Somatomedin-C substitutes for insulin for the growth of mammary epithelial cells from normal virgin mice in serum-free collagen gel cell culture.

  1986cited by this paper
• Stimulation of mammary epithelial cell growth in vitro: interaction of epidermal growth factor and mammogenic hormones.

  1985cited by this paper
• Dual control of cell growth by somatomedins and platelet-derived growth factor.

  1979cited by this paper
• Induction of DNA synthesis in BALB/c 3T3 cells by serum components: reevaluation of the commitment process.

  1977cited by this paper

• Optimization of serum-free medium supplemented with microalgal extract using response surface methodology for human fibroblast culture

  2026cites this paper
• Heparan Sulfate-Collagen Surface Multilayers Support Serum-Free Microcarrier Culture of Mesenchymal Stem Cells.

  2024cites this paper
• Lidocaine Inhibited Tendon Cell Proliferation and Extracellular Matrix Production by Down Regulation of Cyclin A, CDK2, Type I and Type III Collagen Expression

  2022cites this paper
• Design, Synthesis, and Molecular Docking Studies of Some New Quinoxaline Derivatives as EGFR Targeting Agents

  2022cites this paper
• Cyclin-dependent kinase inhibitors (CDKIs) and the DNA damage response: The link between signaling pathways and cancer.

  2021cites this paper
• Evaluation of antioxidant and anticancer activity of crude extract and different fractions of Chlorella vulgaris axenic culture grown under various concentrations of copper ions

  2021cites this paper
• MiR-204-5p promotes lipid synthesis in mammary epithelial cells by targeting SIRT1.

  2020cites this paper
• IGF1R constitutive activation expands luminal progenitors and influences lineage differentiation during breast tumorigenesis.

  2020cites this paper
• Transient Cell-to-Cell Signaling Before Mitosis in Cultures of Human Bone Marrow-Derived Mesenchymal Stem/Stromal Cells

  2019cites this paper
• Pharmacology Evaluation of Bioactive Compounds that Regulate Cervical Cancer Cells

  2019cites this paper
• Egr-1 Maintains NSC Proliferation and Its Overexpression Counteracts Cell Cycle Exit Triggered by the Withdrawal of Epidermal Growth Factor

  2018cites this paper
• Role of insulin-like growth factor (IGF) axis in the development of tamoxifen resistance in breast cancer epithelial cells

  2015cites this paper
• Role of IGF1R in Breast Cancer Subtypes, Stemness, and Lineage Differentiation

  2015cites this paper
• Platelet‐rich plasma increases proliferation of tendon cells by modulating Stat3 and p27 to up‐regulate expression of cyclins and cyclin‐dependent kinases

  2015cites this paper
• The role of β1-integrin in normal and oncogene-mediated proliferation in breast epithelia

  2015influential citation
• BMP-6 inhibits cell proliferation by targeting microRNA-192 in breast cancer.

  2013cites this paper
• Reprogramming non-mammary and cancer cells in the developing mouse mammary gland.

  2012cites this paper
• Platelet-rich plasma induces increased expression of G1 cell cycle regulators, type I collagen, and matrix metalloproteinase-1 in human skin fibroblasts.

  2011cites this paper
• Platelet-rich plasma induces increased expression of G 1 cell cycle regulators , type I collagen , and matrix metalloproteinase-1 in human skin fibroblasts

  2011cites this paper
• Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals.

  2011cites this paper
• Dilong: Role in Peripheral Nerve Regeneration

  2011cites this paper
• Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia

  2011cites this paper
• Etude du facteur de transcription précoce EGR1 dans l'effet anti-prolifératif des ligands de PPARgamma sur les cellules cancéreuses mammaires

  2011cites this paper
• The Expression of T-Box (Tbx3) in the Bovine Mammary Gland

  2011cites this paper
• TSC Regulates Oligodendroglial Differentiation and Myelination in the CNS

  2011cites this paper
• Decreased IGF type 1 receptor signaling in mammary epithelium during pregnancy leads to reduced proliferation, alveolar differentiation, and expression of insulin receptor substrate (IRS)-1 and IRS-2.

  2011cites this paper
• Role and regulation of autophagy in the development of acinar structures formed by bovine BME-UV1 mammary epithelial cells.

  2011cites this paper
• Latent transforming growth factor binding protein 4 (LTBP4) is downregulated in mouse and human DCIS and mammary carcinomas

  2011cites this paper
• Anatomy and Physiology of the Breast

  2010cites this paper
• The Normal Microenvironment Directs Mammary Gland Development

  2010cites this paper
• Reprogramming cell fates in the mammary microenvironment

  2009cites this paper
• Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

  2009cites this paper
• IGF-I, GH, and Sex Steroid Effects in Normal Mammary Gland Development

  2008cites this paper
• Rhein reverses the diabetic phenotype of mesangial cells over‐expressing the glucose transporter (GLUT1) by inhibiting the hexosamine pathway

  2008cites this paper
• IGF Ligand and Receptor Regulation of Mammary Development

  2008cites this paper
• Effects of estradiol and medroxyprogesterone acetate on expression of the cell cycle proteins cyclin D1, p21 and p27 in cultured human breast tissues

  2008cites this paper
• Categorization of Mammographic Density for Breast Cancer

  2008cites this paper
• Latent transforming growth factor binding protein 4 (LTBP‐4) is downregulated in human mammary adenocarcinomas in vitro and in vivo

  2007cites this paper
• Serum Epidermal Growth Factor in Cancer Breast

  2007cites this paper
• Epithelial-specific and stage-specific functions of insulin-like growth factor-I during postnatal mammary development.

  2006cites this paper
• Cell cycle control in breast cancer cells

  2006influential citation
• Progesterone stimulates mammary gland ductal morphogenesis by synergizing with and enhancing insulin-like growth factor-I action.

  2005cites this paper
• Clinical significance of categorisation of mammographic density for breast cancer prognosis.

  2005cites this paper
• Protein 4.1B expression is induced in mammary epithelial cells during pregnancy and regulates their proliferation

  2005cites this paper